This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Jul;8(7):566-567.

doi: 10.1016/S2215-0366(21)00200-5.

Long-acting injectable versus oral antipsychotics for schizophrenia

Klaus Munkholm¹

Affiliations

Affiliation

¹ Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark. Electronic address: kmunkholm@health.sdu.dk.

PMID: 34147176
DOI: 10.1016/S2215-0366(21)00200-5

Comment

Long-acting injectable versus oral antipsychotics for schizophrenia

Klaus Munkholm. Lancet Psychiatry. 2021 Jul.

. 2021 Jul;8(7):566-567.

doi: 10.1016/S2215-0366(21)00200-5.

Author

Klaus Munkholm¹

Affiliation

¹ Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, 5000 Odense, Denmark; Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark. Electronic address: kmunkholm@health.sdu.dk.

PMID: 34147176
DOI: 10.1016/S2215-0366(21)00200-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare no competing interests. Cochrane Denmark is funded by the Danish Government.

Comment in

Long-acting injectable versus oral antipsychotics for schizophrenia - Authors' reply.
Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Kishimoto T, et al. Lancet Psychiatry. 2021 Jul;8(7):567. doi: 10.1016/S2215-0366(21)00203-0. Lancet Psychiatry. 2021. PMID: 34147177 No abstract available.

Comment on

Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU. Kishimoto T, et al. Lancet Psychiatry. 2021 May;8(5):387-404. doi: 10.1016/S2215-0366(21)00039-0. Epub 2021 Apr 13. Lancet Psychiatry. 2021. PMID: 33862018

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information